<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" article-type="discussion">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title-group>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2026.1734857</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Opinion</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>From vision correction to health promotion: a public health approach to myopia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Challa</surname> <given-names>Naveen Kumar</given-names></name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<uri xlink:href="https://loop.frontiersin.org/people/3260156"/>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Department of Optometry, College of Applied Medical Sciences, Qassim University</institution>, <city>Buraidah</city>, <country country="sa">Saudi Arabia</country></aff>
<author-notes>
<corresp id="c001"><label>&#x0002A;</label>Correspondence: Naveen Kumar Challa, <email xlink:href="mailto:n.challa@qu.edu.sa">n.challa@qu.edu.sa</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-03-03">
<day>03</day>
<month>03</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>14</volume>
<elocation-id>1734857</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2026 Challa.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Challa</copyright-holder>
<license>
<ali:license_ref start_date="2026-03-03">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>clinical practice</kwd>
<kwd>health promotion</kwd>
<kwd>myopia</kwd>
<kwd>public health</kwd>
<kwd>quality of life</kwd>
</kwd-group>
<funding-group>
  <funding-statement>The author(s) declared that financial support was not received for this work and/or its publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="15"/>
<page-count count="3"/>
<word-count count="1568"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Public Health Education and Promotion</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<label>1</label>
<title>Introduction</title>
<p>Myopia, or nearsightedness, is rising at an alarming rate and is rapidly becoming a global public health concern. By 2050, nearly half of the world&#x00027;s population is expected to be myopic (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). While glasses, contact lenses, and laser surgery have long served as effective methods for vision correction, the unprecedented rise in myopia demands a more comprehensive and patient-centered response one that not only addresses refractive error but also considers lifestyle, emotional wellbeing, and long-term eye health.</p></sec>
<sec id="s2">
<label>2</label>
<title>Beyond vision correction: the evolution of myopia management</title>
<p>In recent years, myopia management has evolved well-beyond the goal of simply improving visual acuity. Treatments such as orthokeratology (Ortho-K) lenses, low-dose atropine eye drops, and peripheral defocus contact lenses have shown significant promise in slowing myopia progression (<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>). However, these interventions are not standalone solutions. Their effectiveness is influenced by several factors, including patient consistency, timely access to treatment, and personalized care plans (<xref ref-type="bibr" rid="B10">10</xref>). It is not just a matter of having the right tools, it is about ensuring they are used in ways that align with the patient&#x00027;s daily life and long-term needs.</p></sec>
<sec id="s3">
<label>3</label>
<title>Lifestyle factors and modern challenges</title>
<p>Lifestyle also plays a critical role in myopia development and progression. Research indicates that children who spend more time outdoors and limit screen exposure tend to have a lower risk of worsening myopia (<xref ref-type="bibr" rid="B11">11</xref>). While this advice may appear straightforward, the reality is more complex. In today&#x00027;s digitally driven world, screens are integrated into nearly every aspect of a child&#x00027;s life from education and communication to entertainment. Encouraging outdoor activity and setting boundaries around screen time now require deliberate, coordinated efforts by parents, teachers, and healthcare providers alike.</p></sec>
<sec id="s4">
<label>4</label>
<title>Emotional and psychological dimensions of myopia</title>
<p>The impact of myopia extends beyond the physical challenges of blurred vision. For many children and adolescents, it also brings emotional and psychological burdens (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Difficulty seeing the board in class, squinting during daily tasks, or feelings of self-consciousness from wearing glasses can negatively affect self-confidence and peer interactions. A truly patient-first approach must go beyond the clinical setting to include emotional support, open dialogue, and accessible education about eye health. When families understand the nature of myopia and are supported without fear or confusion, they are more empowered to make informed decisions.</p></sec>
<sec id="s5">
<label>5</label>
<title>The expanding role of eye care providers</title>
<p>Eye care providers play a pivotal role in this evolving model of care. They must embrace a broader view, one that includes not only flexible and individualized treatment plans but also active patient education and the thoughtful integration of technology. Digital health tools, including telemedicine and mobile apps, can facilitate ongoing engagement by making it easier for patients to track vision changes, attend follow-up appointments, and communicate with providers (<xref ref-type="bibr" rid="B14">14</xref>). These innovations can enhance both accessibility and adherence, particularly in younger or busy populations.</p></sec>
<sec id="s6">
<label>6</label>
<title>Bridging the gap: equity and access</title>
<p>Nevertheless, equity in access remains a critical challenge. Many families face significant barriers such as financial constraints or geographic isolation, which limit their ability to receive timely and specialized eye care (<xref ref-type="bibr" rid="B15">15</xref>). This gap in access is a major concern that requires collaborative solutions. Policymakers must work to expand public vision care initiatives, and industry stakeholders should prioritize the development of more affordable and scalable treatments. Local solutions such as school-based screenings, community outreach programs, and subsidized services can also help bridge these disparities and ensure early intervention.</p></sec>
<sec id="s7">
<label>7</label>
<title>Toward a patient-centered, preventive future</title>
<p>Ultimately, managing myopia is not solely about reaching 20/20 vision. It is about enhancing quality of life, preserving lifelong eye health, and creating a care model that is as compassionate as it is effective. A modern, human-centered approach to myopia management must blend scientific innovation with practical accessibility, and clinical expertise with emotional understanding.</p>
<p>To address the growing myopia epidemic, we need to move from a reactive model focused only on correction, to a proactive, preventive framework rooted in personalized care. This means integrating medical treatment with lifestyle modification, behavioral change, and technological support. It also requires looking beyond the individual to the broader healthcare systems, education, policy that shape the environment in which patients live.</p></sec>
<sec id="s8">
<label>8</label>
<title>Conclusion: seeing beyond the prescription</title>
<p>As we look toward the future, our goal should be clear: not just better vision, but better lives. Myopia management must evolve into a compassionate, inclusive, and sustainable endeavor one that sees the patient not merely through the lens of their prescription, but as a whole person.</p></sec>
</body>
<back>
<sec sec-type="author-contributions" id="s9">
<title>Author contributions</title>
<p>NC: Conceptualization, Writing &#x02013; review &#x00026; editing, Writing &#x02013; original draft.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. ChatGPT used only for the language improvement purpose only.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holden</surname> <given-names>BA</given-names></name> <name><surname>Fricke</surname> <given-names>TR</given-names></name> <name><surname>Wilson</surname> <given-names>DA</given-names></name> <name><surname>Jong</surname> <given-names>M</given-names></name> <name><surname>Naidoo</surname> <given-names>KS</given-names></name> <name><surname>Sankaridurg</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050</article-title>. <source>Ophthalmology.</source> (<year>2016</year>) <volume>123</volume>:<fpage>1036</fpage>&#x02013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ophtha.2016.01.006</pub-id><pub-id pub-id-type="pmid">26875007</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nouraeinejad</surname> <given-names>A</given-names></name></person-group>. <article-title>More than fifty percent of the world population will be myopic by 2050</article-title>. <source>Beyoglu Eye J.</source> (<year>2021</year>) <volume>6</volume>:<fpage>255</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.14744/bej.2021.27146</pub-id><pub-id pub-id-type="pmid">35059569</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname> <given-names>A</given-names></name> <name><surname>Boldini</surname> <given-names>A</given-names></name> <name><surname>Romano</surname> <given-names>D</given-names></name> <name><surname>Mazza</surname> <given-names>G</given-names></name> <name><surname>Bignotti</surname> <given-names>S</given-names></name> <name><surname>Morescalchi</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Myopia: mechanisms and strategies to slow down its progression</article-title>. <source>J Ophthalmol.</source> (<year>2022</year>) <volume>2022</volume>:<fpage>1004977</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2022/1004977</pub-id><pub-id pub-id-type="pmid">35747583</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>XJ</given-names></name> <name><surname>Zaabaar</surname> <given-names>E</given-names></name> <name><surname>French</surname> <given-names>AN</given-names></name> <name><surname>Tang</surname> <given-names>FY</given-names></name> <name><surname>Kam</surname> <given-names>KW</given-names></name> <name><surname>Tham</surname> <given-names>CC</given-names></name> <etal/></person-group>. <article-title>Advances in myopia control strategies for children</article-title>. <source>Br J Ophthalmol.</source> (<year>2025</year>) <volume>109</volume>:<fpage>165</fpage>&#x02013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1136/bjo-2023-323887</pub-id><pub-id pub-id-type="pmid">38777389</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>PC</given-names></name> <name><surname>Chuang</surname> <given-names>MN</given-names></name> <name><surname>Choi</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Wu</surname> <given-names>G</given-names></name> <name><surname>Ohno-Matsui</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Update in myopia and treatment strategy of atropine use in myopia control</article-title>. <source>Eye.</source> (<year>2019</year>) <volume>33</volume>:<fpage>3</fpage>&#x02013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41433-018-0139-7</pub-id><pub-id pub-id-type="pmid">29891900</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Xu</surname> <given-names>M</given-names></name> <name><surname>San</surname> <given-names>S</given-names></name> <name><surname>Bian</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>H</given-names></name></person-group>. <article-title>Orthokeratology in controlling myopia of children: a meta-analysis of randomized controlled trials</article-title>. <source>BMC Ophthalmol.</source> (<year>2023</year>) <volume>23</volume>:<fpage>441</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12886-023-03175-x</pub-id><pub-id pub-id-type="pmid">37907884</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>K</given-names></name> <name><surname>Si</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Lu</surname> <given-names>X</given-names></name> <name><surname>Bi</surname> <given-names>H</given-names></name></person-group>. <article-title>Orthokeratology for slowing myopia progression in children: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Eye Contact Lens.</source> (<year>2023</year>) <volume>49</volume>:<fpage>404</fpage>&#x02013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ICL.0000000000001006</pub-id><pub-id pub-id-type="pmid">37284749</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repka</surname> <given-names>MX</given-names></name> <name><surname>Weise</surname> <given-names>KK</given-names></name> <name><surname>Chandler</surname> <given-names>DL</given-names></name> <name><surname>Wu</surname> <given-names>R</given-names></name> <name><surname>Melia</surname> <given-names>BM</given-names></name> <name><surname>Manny</surname> <given-names>RE</given-names></name> <etal/></person-group>. <article-title>Low-dose 001% atropine eye drops vs placebo for myopia control: a randomized clinical trial</article-title>. <source>JAMA Ophthalmol</source>. (<year>2023</year>) <volume>141</volume>:<fpage>756</fpage>&#x02013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2023.2855</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>H</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Wei</surname> <given-names>Q</given-names></name> <name><surname>Zhong</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>M</given-names></name> <name><surname>Li</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Myopia control efficacy of peripheral defocus soft contact lenses in children and adolescents: a meta-analysis</article-title>. <source>Eur J Ophthalmol.</source> (<year>2024</year>) <volume>34</volume>:<fpage>1408</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1177/11206721241229474</pub-id><pub-id pub-id-type="pmid">38298013</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tariq</surname> <given-names>F</given-names></name> <name><surname>Mobeen</surname> <given-names>R</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Lin</surname> <given-names>X</given-names></name> <name><surname>Bao</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Advances in myopia prevention strategies for school-aged children: a comprehensive review</article-title>. <source>Front Public Health.</source> (<year>2023</year>) <volume>11</volume>:<fpage>1226438</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2023.1226438</pub-id><pub-id pub-id-type="pmid">37655278</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname> <given-names>S</given-names></name> <name><surname>El Kareh</surname> <given-names>A</given-names></name> <name><surname>Qureshi</surname> <given-names>M</given-names></name> <name><surname>Lee</surname> <given-names>DM</given-names></name> <name><surname>Sun</surname> <given-names>CH</given-names></name> <name><surname>Lam</surname> <given-names>JS</given-names></name> <etal/></person-group>. <article-title>The influence of the environment and lifestyle on myopia</article-title>. <source>J Physiol Anthropol.</source> (<year>2024</year>) <volume>43</volume>:<fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40101-024-00354-7</pub-id><pub-id pub-id-type="pmid">38297353</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>LY</given-names></name> <name><surname>Sun</surname> <given-names>H</given-names></name> <name><surname>Hu</surname> <given-names>M</given-names></name> <name><surname>Jiang</surname> <given-names>YH</given-names></name> <name><surname>Luo</surname> <given-names>ZH</given-names></name></person-group>. <article-title>Mental health status of parents of young patients with high myopia</article-title>. <source>J Int Med Res.</source> (<year>2020</year>) <volume>48</volume>:<fpage>0300060519873474</fpage>. doi: <pub-id pub-id-type="doi">10.1177/0300060519873474</pub-id><pub-id pub-id-type="pmid">31992100</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname> <given-names>L</given-names></name> <name><surname>Berlin</surname> <given-names>KS</given-names></name></person-group>. <article-title>Psychological stress in childhood and myopia development</article-title>. <source>Optom Vis Perf.</source> (<year>2014</year>) <volume>2</volume>:<fpage>289</fpage>&#x02013;<lpage>96</lpage>.</mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Yip</surname> <given-names>MY</given-names></name> <name><surname>Ting</surname> <given-names>DS</given-names></name> <name><surname>Ang</surname> <given-names>M</given-names></name></person-group>. <article-title>Artificial intelligence and digital solutions for myopia</article-title>. <source>Taiwan J Ophthalmol.</source> (<year>2023</year>) <volume>13</volume>:<fpage>142</fpage>&#x02013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.4103/tjo.TJO-D-23-00032</pub-id><pub-id pub-id-type="pmid">37484621</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname> <given-names>MJ</given-names></name> <name><surname>Ramke</surname> <given-names>J</given-names></name> <name><surname>Marques</surname> <given-names>AP</given-names></name> <name><surname>Bourne</surname> <given-names>RR</given-names></name> <name><surname>Congdon</surname> <given-names>N</given-names></name> <name><surname>Jones</surname> <given-names>I</given-names></name> <etal/></person-group>. <article-title>The lancet global health commission on global eye health: vision beyond 2020</article-title>. <source>Lancet Glob Health.</source> (<year>2021</year>) <volume>9</volume>:<fpage>e489</fpage>&#x02013;<lpage>551</lpage>. <pub-id pub-id-type="pmid">33607016</pub-id></mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1557820/overview">Ahmad Neyazi</ext-link>, Afghanistan Center for Epidemiological Studies, Afghanistan</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0002">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/324704/overview">Smitha Jasper</ext-link>, Christian Medical College and Hospital, India</p>
</fn>
</fn-group>
</back>
</article>